sglt2 inhibitors and glp-1 receptor agonists together Diabetic Agents, From Metformin to GLP1 Agonists: JACC Focus Seminar The Role of SGLT 2
Description
He L, Wang J, Ping F, et al
They also slow progression of diabetic kidney disease and are associated with beneficial effects like lower blood pressure and improved lipid profiles ( [8] ) ( [7] )
Hepatology 2018;67:328-357
In a JAMA, researchers analyzed a wide population of people with type 2 diabetes and reported that GLP-1RA drugs do not increase the risk of pancreatic cancer compared to basal insulin over a 7-year period
Is a $50 copay manageable
